Advanced in Dowling-Meara Epidermolysis Bullosa Simplex

Pierre Vabres

Dijon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Dowling-Meara Epidermolysis Bullosa Simplex
Dijon, FR 
OverviewLocationsClinical Research

Overview

Pierre Vabres practices in Dijon, France. Mr. Vabres is rated as an Advanced expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. His top areas of expertise are Hypomelanosis of Ito, Linear Nevus Sebaceous Syndrome, Mosaicism, and Megalencephaly-Capillary Malformation Syndrome.

His clinical research consists of co-authoring 152 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Dowling-Meara Epidermolysis Bullosa Simplex.

Gender
Male

Locations

Dijon, France
Other Locations
Paris, France
Bourgogne, France
2, Place Victor Pauchet, Amiens, 80000, France
Hospices Civils de Lyon
Lyon, France
Nantes, France
Auxerre, France
Nice, 06202, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Enrollment Status: Recruiting
Publish Date: February 11, 2025
Intervention Type: Other
Treatment of Superficial Voluminous Complicated Slow-flow Vascular Malformations With Sirolimus: a Phase 2 Trial in Children Observational-phase Designed
Treatment of Superficial Voluminous Complicated Slow-flow Vascular Malformations With Sirolimus: a Phase 2 Trial in Children Observational-phase Designed
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Drug
Study Phase: Phase 2
Non-randomised Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA- Related Overgrowth
Non-randomised Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA- Related Overgrowth
Enrollment Status: Completed
Publish Date: October 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

151 Total Publications

Double non-allelic somatic activating oncogene variants in a series of mosaic vascular anomalies.
Double non-allelic somatic activating oncogene variants in a series of mosaic vascular anomalies.
Journal: The British journal of dermatology
Published: June 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vabres's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 26 Advanced Conditions
    View All 61 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile